Research Output per year
Research Output per year
Personal profile
Research interests
My work has been devoted primarily to research on molecular mechanisms of resistance to antimalarial drugs using classical genetics tools combined with new concepts and technologies of genomics and bioinformatics. More recently, I have focused on the application of genomics concepts for the discovery of new therapies and vaccines against tropical diseases. I have worked in partnership with institutions from countries where different tropical parasites are a substantial public health problem, including in Brazil, where I was a Visiting Professor between 2011 and 2016.
Education/Academic qualification
Genetics, Doctorate, University of Edinburgh
Award Date: 15 Jun 2001
External positions
Assistant Professor, Universidade Federal de Goiás
2 Jan 2011 → 31 Dec 2016Keywords
- L Education (General)
- RM Therapeutics. Pharmacology
Fingerprint
Dive into the research topics where Pedro Vitor Lemos Cravo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 42 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output at NOVA
-
Computational chemogenomics drug repositioning strategy enables the discovery of epirubicin as a new repurposed hit for Plasmodium falciparum and P. vivax
Ferreira, L. T., Rodrigues, J., Cassiano, G. C., Tavella, T. A., Tomaz, K. C. P., Baia-Da-Silva, D. C., Souza, M. F., do Nascimento Lima, M. N., Mottin, M., Almeida, L. D., Calit, J., de Barros Puça, M. C. S., Melo, G. C., Bargieri, D. Y., Lopes, S. C. P., Lacerda, M. V. G., Bilsland, E., Sunnerhagen, P., Neves, B. J., Andrade, C. H. & 2 others, , Sep 2020, In : Antimicrobial Agents and Chemotherapy. Vol. 64, n.º 9, p. e02041-e02058 17 p., e02041-19.Research output: Contribution to journal › Article
Open Access -
Efflux pump inhibitors as a promising adjunct therapy against drug resistant tuberculosis: a new strategy to revisit mycobacterial targets and repurpose old drugs
Rodrigues, L., Cravo, P. & Viveiros, M., 2 Aug 2020, In : Expert Review of Anti-Infective Therapy. 18, 8, p. 1-17 17 p.Research output: Contribution to journal › Review article
Open AccessFile2 Citations (Scopus)1 Downloads (Pure) -
Erratum: computational chemogenomics drug repositioning strategy enables the discovery of epirubicin as a new repurposed hit for plasmodium falciparum and P. vivax (Antimicrobial Agents and Chemotherapy (2020) 64:9 (e02041-19) DOI: 10.1128/AAC.02041-19)
Ferreira, L. T., Rodrigues, J., Cassiano, G. C., Tavella, T. A., Tomaz, K. C. P., Baia-Da-Silva, D. C., Souza, M. F., do Nascimento Lima, M. N., Mottin, M., Almeida, L. D., Calit, J., de Barros Puça, M. C. S., Melo, G. C., Bargieri, D. Y., Lopes, S. C. P., Lacerda, M. V. G., Bilsland, E., Sunnerhagen, P., Neves, B. J., Andrade, C. H. & 2 others, , Oct 2020, In : Antimicrobial Agents and Chemotherapy. Vol. 64, n.º 11, p. e01843 1 p., e01843.Research output: Contribution to journal › Comment/debate
Open Access -
Targeting malaria protein kinases
Cassiano, G. C., Tavella, T. A., Nascimento, M. N., Rodrigues, D. A., Cravo, P. V. L., Andrade, C. H. & Costa, F. T. M., 2020, (Accepted/In press) Advances in protein chemistry and structural biology. (Advances in Protein Chemistry and Structural Biology).Research output: Chapter in Book/Report/Conference proceeding › Chapter
-
Targeting membrane transporters and energy metabolism in Mycobacterium tuberculosis through in silico drug repurposing
Rodrigues, L., Cravo, P. V. L. & Viveiros, M., 2020.Research output: Contribution to conference › Poster